Investors had a roughly six-week window of opportunity earlier this year to buy Cognex (CGNX) at what I think is a good price relative to the company’s financial prospects. Since then, the shares have not only participated in the post-panic recovery, but also picked up some momentum as a reshoring play. The company posting a stronger than expected first quarter and management sounding fairly bullish on the company’s recovery prospects after COVID-19 has only added to that momentum.
I’m skeptical regarding the reshoring angle, but I am still very bullish about the long-term